Literature DB >> 17292840

Hydrophobic sliding: a possible mechanism for drug resistance in human immunodeficiency virus type 1 protease.

Jennifer E Foulkes-Murzycki1, Walter Robert Peter Scott, Celia A Schiffer.   

Abstract

Hydrophobic residues outside the active site of HIV-1 protease frequently mutate in patients undergoing protease inhibitor therapy; however, the mechanism by which these mutations confer drug resistance is not understood. From analysis of molecular dynamics simulations, 19 core hydrophobic residues appear to facilitate the conformational changes that occur in HIV-1 protease. The hydrophobic core residues slide by each other, exchanging one hydrophobic van der Waal contact for another, with little energy penalty, while maintaining many structurally important hydrogen bonds. Such hydrophobic sliding may represent a general mechanism by which proteins undergo conformational changes. Mutation of these residues in HIV-1 protease would alter the packing of the hydrophobic core, affecting the conformational flexibility of the protease. Therefore these residues impact the dynamic balance between processing substrates and binding inhibitors, and thus contribute to drug resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292840      PMCID: PMC2044563          DOI: 10.1016/j.str.2007.01.006

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  32 in total

1.  Characterization of two hydrophobic methyl clusters in HIV-1 protease by NMR spin relaxation in solution.

Authors:  R Ishima; J M Louis; D A Torchia
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

2.  Relation between sequence and structure of HIV-1 protease inhibitor complexes: a model system for the analysis of protein flexibility.

Authors:  V Zoete; O Michielin; M Karplus
Journal:  J Mol Biol       Date:  2002-01-04       Impact factor: 5.469

3.  Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes.

Authors:  Moses Prabu-Jeyabalan; Ellen Nalivaika; Celia A Schiffer
Journal:  Structure       Date:  2002-03       Impact factor: 5.006

4.  Closing of the flaps of HIV-1 protease induced by substrate binding: a model of a flap closing mechanism in retroviral aspartic proteases.

Authors:  Gergely Tóth; Attila Borics
Journal:  Biochemistry       Date:  2006-05-30       Impact factor: 3.162

5.  Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance.

Authors:  L Hong; X C Zhang; J A Hartsuck; J Tang
Journal:  Protein Sci       Date:  2000-10       Impact factor: 6.725

6.  Folded monomer of HIV-1 protease.

Authors:  R Ishima; R Ghirlando; J Tözsér; A M Gronenborn; D A Torchia; J M Louis
Journal:  J Biol Chem       Date:  2001-10-11       Impact factor: 5.157

7.  Rapid structural fluctuations of the free HIV protease flaps in solution: relationship to crystal structures and comparison with predictions of dynamics calculations.

Authors:  Darón I Freedberg; Rieko Ishima; Jaison Jacob; Yun-Xing Wang; Irina Kustanovich; John M Louis; Dennis A Torchia
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

8.  Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance.

Authors:  W R Scott; C A Schiffer
Journal:  Structure       Date:  2000-12-15       Impact factor: 5.006

9.  How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease.

Authors:  M Prabu-Jeyabalan; E Nalivaika; C A Schiffer
Journal:  J Mol Biol       Date:  2000-09-01       Impact factor: 5.469

10.  A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance.

Authors:  Salman Muzammil; Patrick Ross; Ernesto Freire
Journal:  Biochemistry       Date:  2003-01-28       Impact factor: 3.162

View more
  38 in total

1.  A comparative study of HIV-1 and HTLV-I protease structure and dynamics reveals a conserved residue interaction network.

Authors:  Pia Rücker; Anselm H C Horn; Heike Meiselbach; Heinrich Sticht
Journal:  J Mol Model       Date:  2011-01-29       Impact factor: 1.810

2.  The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways.

Authors:  Rajintha M Bandaranayake; Madhavi Kolli; Nancy M King; Ellen A Nalivaika; Annie Heroux; Junko Kakizawa; Wataru Sugiura; Celia A Schiffer
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

3.  Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts.

Authors:  Zhanglong Liu; Thomas M Casey; Mandy E Blackburn; Xi Huang; Linh Pham; Ian Mitchelle S de Vera; Jeffrey D Carter; Jamie L Kear-Scott; Angelo M Veloro; Luis Galiano; Gail E Fanucci
Journal:  Phys Chem Chem Phys       Date:  2016-02-17       Impact factor: 3.676

4.  Statistical coupling analysis of aspartic proteinases based on crystal structures of the Trichoderma reesei enzyme and its complex with pepstatin A.

Authors:  Alessandro S Nascimento; Sandra Krauchenco; Alexander M Golubev; Alla Gustchina; Alexander Wlodawer; Igor Polikarpov
Journal:  J Mol Biol       Date:  2008-07-22       Impact factor: 5.469

5.  Room Temperature Neutron Crystallography of Drug Resistant HIV-1 Protease Uncovers Limitations of X-ray Structural Analysis at 100 K.

Authors:  Oksana Gerlits; David A Keen; Matthew P Blakeley; John M Louis; Irene T Weber; Andrey Kovalevsky
Journal:  J Med Chem       Date:  2017-02-28       Impact factor: 7.446

6.  Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance.

Authors:  Mina Henes; Gordon J Lockbaum; Klajdi Kosovrasti; Florian Leidner; Gily S Nachum; Ellen A Nalivaika; Sook-Kyung Lee; Ean Spielvogel; Shuntai Zhou; Ronald Swanstrom; Daniel N A Bolon; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  ACS Chem Biol       Date:  2019-08-13       Impact factor: 5.100

7.  Atomistic simulations of the HIV-1 protease folding inhibition.

Authors:  Gennady Verkhivker; Guido Tiana; Carlo Camilloni; Davide Provasi; Ricardo A Broglia
Journal:  Biophys J       Date:  2008-03-28       Impact factor: 4.033

8.  Effects of Hinge-region Natural Polymorphisms on Human Immunodeficiency Virus-Type 1 Protease Structure, Dynamics, and Drug Pressure Evolution.

Authors:  Zhanglong Liu; Xi Huang; Lingna Hu; Linh Pham; Katye M Poole; Yan Tang; Brian P Mahon; Wenxing Tang; Kunhua Li; Nathan E Goldfarb; Ben M Dunn; Robert McKenna; Gail E Fanucci
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

9.  Modulation of HIV protease flexibility by the T80N mutation.

Authors:  Hao Zhou; Shangyang Li; John Badger; Ellen Nalivaika; Yufeng Cai; Jennifer Foulkes-Murzycki; Celia Schiffer; Lee Makowski
Journal:  Proteins       Date:  2015-09-29

10.  A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant.

Authors:  Michael J Giffin; Holly Heaslet; Ashraf Brik; Ying-Chuan Lin; Gabrielle Cauvi; Chi-Huey Wong; Duncan E McRee; John H Elder; C David Stout; Bruce E Torbett
Journal:  J Med Chem       Date:  2008-09-30       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.